J

Jeisys Medical Inc
KOSDAQ:287410

Watchlist Manager
Jeisys Medical Inc
KOSDAQ:287410
Watchlist
Price: 12 900 KRW 0.16%
Market Cap: 976.4B KRW
Have any thoughts about
Jeisys Medical Inc?
Write Note

Jeisys Medical Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jeisys Medical Inc
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
J
Jeisys Medical Inc
KOSDAQ:287410
Interest Income Expense
â‚©235.1m
CAGR 3-Years
N/A
CAGR 5-Years
18%
CAGR 10-Years
N/A
Dentium Co Ltd
KRX:145720
Interest Income Expense
-â‚©5.3B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Biodyne Co Ltd
KOSDAQ:314930
Interest Income Expense
â‚©996.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Interest Income Expense
-â‚©60.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lutronic Corp
KOSDAQ:085370
Interest Income Expense
â‚©1B
CAGR 3-Years
-14%
CAGR 5-Years
101%
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Interest Income Expense
â‚©4.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jeisys Medical Inc
Glance View

Market Cap
974B KRW
Industry
Health Care

Jeisys Medical, Inc. manufactures and develops products used by plastic surgeons, dermatologist, physicians and health professionals. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-05-08. The firm manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.

Intrinsic Value
16 817.25 KRW
Undervaluation 23%
Intrinsic Value
Price
J

See Also

What is Jeisys Medical Inc's Interest Income Expense?
Interest Income Expense
235.1m KRW

Based on the financial report for Jun 30, 2024, Jeisys Medical Inc's Interest Income Expense amounts to 235.1m KRW.

What is Jeisys Medical Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
18%

Back to Top